HER2乳がん検査市場(検査タイプ。免疫組織化学[IHC]および蛍光/発色性in situハイブリダイゼーション[FISH/CISH]、エンドユーザー:世界の産業分析、サイズ、シェア、成長、傾向、予測、2021-2031年HER2 Breast Cancer Test Market (Test Type: Immunohistochemistry [IHC] and Fluorescence/Chromogenic In Situ Hybridization [FISH/CISH]; and End-user: Hospitals and Diagnostic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 錠剤硬度計の市場 - レポートの範囲 TMRの調査レポート「錠剤硬度計の世界市場」は、2021年から2031年までの予測期間中に市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調... もっと見る
サマリー錠剤硬度計の市場 - レポートの範囲TMRの調査レポート「錠剤硬度計の世界市場」は、2021年から2031年までの予測期間中に市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会も調査しています。2020年を基準年、2031年を予測年として、2017年から2031年までの錠剤硬度計の世界市場の売上を掲載しています。また、2021年から2031年までの錠剤硬度計の世界市場の複合年間成長率(CAGR %)を記載しています。 本レポートは、広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーにアナリストがインタビューを行うなど、調査作業の大部分を一次調査が占めている。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、錠剤硬度計市場を理解することに努めました。 二次調査には、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれます。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界の錠剤硬度計市場の様々な属性を調査しました。 本レポートには、調査範囲に含まれる様々なセグメントの成長行動のスナップショットとともに、精巧なエグゼクティブサマリーが含まれています。さらに、このレポートは、世界の錠剤硬度計市場の変化する競争力学に光を投げかけています。これらは、既存の市場プレーヤーだけでなく、世界の錠剤硬度計市場への参入に関心のあるエンティティにとって貴重なツールになります。 本レポートでは、世界の錠剤硬度計市場の競争環境について掘り下げています。世界の錠剤硬度計市場で事業を展開する主要企業を特定し、各企業を様々な属性でプロファイルしています。会社概要、財務状況、最近の開発、SWOTは、本レポートで紹介されている世界の錠剤硬度計市場のプレイヤーの属性です。 錠剤硬度計の市場レポートで回答した主要な質問 予測期間中の全地域における錠剤硬度計の売上高/収入はどの程度か? 世界の錠剤硬度計市場におけるビジネスチャンスは? 市場における主なドライバー、阻害要因、機会、脅威は何か? 予測期間中に最も速いCAGRで拡大すると思われる地域市場はどこか? 2031年に世界で最も高い収益を上げると予想されるセグメントは? 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは? 世界市場で事業を展開する各企業の市場ポジションは? 錠剤硬度計の市場 - 調査目的と調査アプローチ 錠剤硬度計の世界市場に関する包括的なレポートは、まず概要から始まり、次に調査範囲と目的について説明しています。本調査の目的、市場で活動する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。 読みやすさを考慮し、各セクションを細かく分割した章立てのレイアウトで編集しています。また、グラフや表が適切に配置され、網羅的にまとめられています。主要セグメントの実績値および予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間終了時の主要セグメントの市場シェアを比較することができます。 本レポートでは、錠剤硬度計の世界市場を製品タイプ、機能、地域の観点から分析しています。各基準の主要セグメントを詳細に調査し、2031年末時点の各市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界の錠剤硬度計市場への投資について、十分な情報に基づいたビジネス上の意思決定を行うことができます。 目次1. Preface1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 4. Market Overview 4.1. Introduction 4.2. Global HER2 Breast Cancer Test Market Forecast 4.3. Global HER2 Breast Cancer Test Market Outlook 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity 5. Key Insights 5.1. Revenue Model 5.2. Pricing Analysis 5.3. COVID-19 Impact Analysis 6. Global HER2 Breast Cancer Test Market Analysis, by Test Type 6.1. Introduction 6.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type 6.3. Global HER2 Breast Cancer Test Market Forecast, by Test Type 6.3.1. Immunohistochemistry (IHC) 6.3.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 6.4. Global HER2 Breast Cancer Test Market Analysis, by Test Type 6.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type 7. Global HER2 Breast Cancer Test Market Analysis, by End-user 7.1. Introduction 7.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by End-user 7.3. Global HER2 Breast Cancer Test Market Forecast, by End-user 7.3.1. Hospitals 7.3.2. Diagnostic Laboratories 7.4. Global HER2 Breast Cancer Test Market Analysis, by End-user 7.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by End-user 8. Global HER2 Breast Cancer Test Market Analysis, by Region 8.1. Introduction 8.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Region 8.3. Global HER2 Breast Cancer Test Market Forecast, by Region 8.3.1. North America 8.3.2. Europe 8.3.3. Asia Pacific 8.3.4. Latin America 8.3.5. Middle East & Africa 9. North America HER2 Breast Cancer Test Market Analysis 9.1. North America HER2 Breast Cancer Test Market Overview 9.2. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country 9.2.1. U.S. 9.2.2. Canada 9.3. North America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type 9.4. North America HER2 Breast Cancer Test Market Forecast, by Test Type 9.4.1. Immunohistochemistry (IHC) 9.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 9.5. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user 9.6. North America HER2 Breast Cancer Test Market Forecast, by End-user 9.6.1. Hospitals 9.6.2. Diagnostic Laboratories 10. Europe HER2 Breast Cancer Test Market Analysis 10.1. Europe HER2 Breast Cancer Test Market Overview 10.2. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region 10.2.1. Germany 10.2.2. U.K. 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Rest of Europe 10.3. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type 10.4. Europe HER2 Breast Cancer Test Market Forecast, by Test Type 10.4.1. Immunohistochemistry (IHC) 10.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 10.5. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user 10.6. Europe HER2 Breast Cancer Test Market Forecast, by End-user 10.6.1. Hospitals 10.6.2. Diagnostic Laboratories 11. Asia Pacific HER2 Breast Cancer Test Market Analysis 11.1. Asia Pacific HER2 Breast Cancer Test Market Overview 11.2. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region 11.2.1. China 11.2.2. Japan 11.2.3. India 11.2.4. Australia & New Zealand 11.2.5. Rest of Asia Pacific 11.3. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type 11.4. Asia Pacific HER2 Breast Cancer Test Market Forecast, by Test Type 11.4.1. Immunohistochemistry (IHC) 11.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 11.5. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user 11.6. Asia Pacific HER2 Breast Cancer Test Market Forecast, by End-user 11.6.1. Hospitals 11.6.2. Diagnostic Laboratories 12. Latin America HER2 Breast Cancer Test Market Analysis 12.1. Latin America HER2 Breast Cancer Test Market Overview 12.2. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region 12.2.1. Brazil 12.2.2. Mexico 12.2.3. Rest of Latin America 12.3. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type 12.4. Latin America HER2 Breast Cancer Test Market Forecast, by Test Type 12.4.1. Immunohistochemistry (IHC) 12.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 12.5. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user 12.6. Latin America HER2 Breast Cancer Test Market Forecast, by End-user 12.6.1. Hospitals 12.6.2. Diagnostic Laboratories 13. Middle East & Africa HER2 Breast Cancer Test Market Analysis 13.1. Middle East & Africa HER2 Breast Cancer Test Market Overview 13.2. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region 13.2.1. GCC Countries 13.2.2. South Africa 13.2.3. Rest of Middle East & Africa 13.3. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type 13.4. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by Test Type 13.4.1. Immunohistochemistry (IHC) 13.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 13.5. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user 13.6. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by End-user 13.6.1. Hospitals 14. Competition Landscape 14.1. Market Player - Competition Matrix (by tier and size of companies) 14.2. Market Share Analysis, by Company, 2019 14.3. Company Profiles 14.3.1. Abbott Laboratories 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Portfolio 14.3.1.3. SWOT Analysis 14.3.1.4. Strategic Overview 14.3.2. BioGenex 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Portfolio 14.3.2.3. SWOT Analysis 14.3.2.4. Strategic Overview 14.3.3. Agilent Technologies, Inc. 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Portfolio 14.3.3.3. SWOT Analysis 14.3.3.4. Strategic Overview 14.3.4. Leica Biosystems 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Portfolio 14.3.4.3. SWOT Analysis 14.3.4.4. Strategic Overview 14.3.5. Roche 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Portfolio 14.3.5.3. SWOT Analysis 14.3.5.4. Strategic Overview 14.3.6. Mylab Discovery Solutions Pvt. Ltd. 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Portfolio 14.3.6.3. SWOT Analysis 14.3.6.4. Strategic Overview
SummaryTablet Hardness Testers Market – Scope of Report Table of Contents1. Preface1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 4. Market Overview 4.1. Introduction 4.2. Global HER2 Breast Cancer Test Market Forecast 4.3. Global HER2 Breast Cancer Test Market Outlook 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunity 5. Key Insights 5.1. Revenue Model 5.2. Pricing Analysis 5.3. COVID-19 Impact Analysis 6. Global HER2 Breast Cancer Test Market Analysis, by Test Type 6.1. Introduction 6.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Test Type 6.3. Global HER2 Breast Cancer Test Market Forecast, by Test Type 6.3.1. Immunohistochemistry (IHC) 6.3.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 6.4. Global HER2 Breast Cancer Test Market Analysis, by Test Type 6.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by Test Type 7. Global HER2 Breast Cancer Test Market Analysis, by End-user 7.1. Introduction 7.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by End-user 7.3. Global HER2 Breast Cancer Test Market Forecast, by End-user 7.3.1. Hospitals 7.3.2. Diagnostic Laboratories 7.4. Global HER2 Breast Cancer Test Market Analysis, by End-user 7.5. Global HER2 Breast Cancer Test Market Attractiveness Analysis, by End-user 8. Global HER2 Breast Cancer Test Market Analysis, by Region 8.1. Introduction 8.2. Global HER2 Breast Cancer Test Market Value Share Analysis, by Region 8.3. Global HER2 Breast Cancer Test Market Forecast, by Region 8.3.1. North America 8.3.2. Europe 8.3.3. Asia Pacific 8.3.4. Latin America 8.3.5. Middle East & Africa 9. North America HER2 Breast Cancer Test Market Analysis 9.1. North America HER2 Breast Cancer Test Market Overview 9.2. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country 9.2.1. U.S. 9.2.2. Canada 9.3. North America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type 9.4. North America HER2 Breast Cancer Test Market Forecast, by Test Type 9.4.1. Immunohistochemistry (IHC) 9.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 9.5. North America HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user 9.6. North America HER2 Breast Cancer Test Market Forecast, by End-user 9.6.1. Hospitals 9.6.2. Diagnostic Laboratories 10. Europe HER2 Breast Cancer Test Market Analysis 10.1. Europe HER2 Breast Cancer Test Market Overview 10.2. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region 10.2.1. Germany 10.2.2. U.K. 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Rest of Europe 10.3. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type 10.4. Europe HER2 Breast Cancer Test Market Forecast, by Test Type 10.4.1. Immunohistochemistry (IHC) 10.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 10.5. Europe HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user 10.6. Europe HER2 Breast Cancer Test Market Forecast, by End-user 10.6.1. Hospitals 10.6.2. Diagnostic Laboratories 11. Asia Pacific HER2 Breast Cancer Test Market Analysis 11.1. Asia Pacific HER2 Breast Cancer Test Market Overview 11.2. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region 11.2.1. China 11.2.2. Japan 11.2.3. India 11.2.4. Australia & New Zealand 11.2.5. Rest of Asia Pacific 11.3. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type 11.4. Asia Pacific HER2 Breast Cancer Test Market Forecast, by Test Type 11.4.1. Immunohistochemistry (IHC) 11.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 11.5. Asia Pacific HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user 11.6. Asia Pacific HER2 Breast Cancer Test Market Forecast, by End-user 11.6.1. Hospitals 11.6.2. Diagnostic Laboratories 12. Latin America HER2 Breast Cancer Test Market Analysis 12.1. Latin America HER2 Breast Cancer Test Market Overview 12.2. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Country/Sub-region 12.2.1. Brazil 12.2.2. Mexico 12.2.3. Rest of Latin America 12.3. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by Test Type 12.4. Latin America HER2 Breast Cancer Test Market Forecast, by Test Type 12.4.1. Immunohistochemistry (IHC) 12.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 12.5. Latin America HER2 Breast Cancer Test Market Value Share and Attractiveness analysis, by End-user 12.6. Latin America HER2 Breast Cancer Test Market Forecast, by End-user 12.6.1. Hospitals 12.6.2. Diagnostic Laboratories 13. Middle East & Africa HER2 Breast Cancer Test Market Analysis 13.1. Middle East & Africa HER2 Breast Cancer Test Market Overview 13.2. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Country/Sub-region 13.2.1. GCC Countries 13.2.2. South Africa 13.2.3. Rest of Middle East & Africa 13.3. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by Test Type 13.4. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by Test Type 13.4.1. Immunohistochemistry (IHC) 13.4.2. Fluorescence/Chromogenic In Situ Hybridization (FISH/CISH) 13.5. Middle East & Africa HER2 Breast Cancer Test Market Value Share and Attractiveness Analysis, by End-user 13.6. Middle East & Africa HER2 Breast Cancer Test Market Forecast, by End-user 13.6.1. Hospitals 14. Competition Landscape 14.1. Market Player - Competition Matrix (by tier and size of companies) 14.2. Market Share Analysis, by Company, 2019 14.3. Company Profiles 14.3.1. Abbott Laboratories 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.1.2. Product Portfolio 14.3.1.3. SWOT Analysis 14.3.1.4. Strategic Overview 14.3.2. BioGenex 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2.2. Product Portfolio 14.3.2.3. SWOT Analysis 14.3.2.4. Strategic Overview 14.3.3. Agilent Technologies, Inc. 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.3.2. Product Portfolio 14.3.3.3. SWOT Analysis 14.3.3.4. Strategic Overview 14.3.4. Leica Biosystems 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.4.2. Product Portfolio 14.3.4.3. SWOT Analysis 14.3.4.4. Strategic Overview 14.3.5. Roche 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.5.2. Product Portfolio 14.3.5.3. SWOT Analysis 14.3.5.4. Strategic Overview 14.3.6. Mylab Discovery Solutions Pvt. Ltd. 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.6.2. Product Portfolio 14.3.6.3. SWOT Analysis 14.3.6.4. Strategic Overview
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野の最新刊レポート
Transparency Market Research社のその他分野での最新刊レポート
本レポートと同じKEY WORD(breast cancer)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|